With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?

A Mehta, DL Dixon, A Saeed, MS Kelly, M Gulati… - Current cardiology …, 2023 - Springer
Abstract Purpose of Review Statins inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme
A reductase in the liver and reduce atherosclerotic cardiovascular disease (ASCVD) risk by …

Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease

B Delabays, R de La Harpe… - European journal of …, 2023 - academic.oup.com
Aims Population-wide impacts of new guidelines in the primary prevention of atherosclerotic
cardiovascular disease (ASCVD) should be explored in independent cohorts. Assess and …

Serum Cholesterol and Impact of Age on Coronary Heart Disease Death in More Than 4 Million Veterans

XMT Nguyen, YL Ho, Y Li, RJ Song… - Journal of the …, 2023 - Am Heart Assoc
Background The lipid hypothesis postulates that lower blood cholesterol is associated with
reduced coronary heart disease (CHD) risk, which has been challenged by reports of a U …

Cardiovascular Statistics 2021.

CJ Lavie - Progress in cardiovascular diseases, 2021 - europepmc.org
Cardiovascular Statistics 2021. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …

[HTML][HTML] US population qualifying for aspirin use for primary prevention of cardiovascular disease

AL Huang, AM Navar, C Ayers, A Rohatgi… - American Journal of …, 2024 - Elsevier
Objective Aspirin has been used for primary prevention of atherosclerotic cardiovascular
disease (ASCVD) for decades, but this indication has become controversial with recent trial …

Patterns of Statin Therapy Use and Associated Outcomes in Older Veterans Across Kidney Function

G Gjyriqi, A Gross, E Burns, E Gianos, MS Sidhu… - The American Journal of …, 2024 - Elsevier
Background Despite significant morbidity and mortality related to atherosclerotic
cardiovascular disease, to date, most major clinical trials studying the effects of statin …

[PDF][PDF] The effectiveness of turmeric supplementation in reducing low-density lipoprotein cholesterol in adults.

J Hesson - Revista Mexicana de Endocrinología, Metabolismo y …, 2024 - researchgate.net
Esta revisión informa sobre los hallazgos de siete revisiones sistemáticas y metanálisis que
evalúan la efectividad de la cúrcuma como suplemento dietético para reducir el colesterol …

[PDF][PDF] Consumo de Estatinas na Região Centro de Portugal (2010-2021)

C Abrantes, C Coelho, M Castel-Branco… - 2023 - repositorio-aberto.up.pt
Método Foram analisados os dados obtidos da base de dados da Administração Regional
de Saúde (ARS) Centro relativos às estatinas dispensadas nas farmácias comunitárias, nas …

[引用][C] A decade as editor-in-chief of progress in cardiovascular diseases

CJ Lavie - Progress in cardiovascular diseases, 2023 - pubmed.ncbi.nlm.nih.gov

[引用][C] Over a decade as editor-in-chief at progress in cardiovascular diseases.

CJ Lavie - Progress in Cardiovascular Diseases, 2024 - europepmc.org
Over a decade as editor-in-chief at progress in cardiovascular diseases. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …